High-dose-rate (HDR) brachytherapy as monotherapy is a comparatively new brachytherapy procedure for prostate cancer.
Although clinical results are not yet mature enough, it is a highly promising approach in terms of potential benefits for both radiation physics and radiobiology. In this article, we describe our technique for monotherapeutic HDR prostate brachytherapy, as well as the rationale and theoretical background, with educational
Written by:
Yoshioka Y, Suzuki O, Otani Y, Yoshida K, Nose T, Ogawa K. Are you the author?
Department of Radiation Oncology, Osaka University Graduate School of Medicine, Osaka, Japan; Department of Radiology, Osaka Medical College, Osaka, Japan; Department of Radiation Oncology, Nippon Medical School Tama Nagayama Hospital, Tokyo, Japan.
Reference: J Contemp Brachytherapy. 2014 Mar;6(1):91-98.
doi: 10.5114/jcb.2014.42026
PubMed Abstract
PMID: 24790627
UroToday.com Prostate Cancer Section
